title: Allergic fungal sinusitis: a four-year follow-up.
abstract: Allergic fungal sinusitis (AFS), first described over 18 years ago and subsequently identified using established criteria, remains a challenge to treat. Our protocol has included complete functional endoscopic sinus surgery to remove the fungal load and restore physiologic mucous clearance. The patient is treated with prednisone for several months and followed monthly with total serum IgE levels and an established endoscopic mucosal staging system. A group of 11 patients first treated in 1994 and presented at the 1995 American Rhinology Society Spring meeting are being presented again to provide an update on their progress over the past four years. A great deal of experience has been gained from their treatment and has continued to modify our postoperative medical management. An overview of AFS, our evolving and current treatment protocol, and possible future trends are discussed in this paper.
authors.affiliation: Georgia Nasal and Sinus Institute, Savannah, USA.
authors.forename: F A
authors.initials: FA
authors.lastname: Kuhn
authors.forename: A R
authors.initials: AR
authors.lastname: Javer
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004724:Endoscopy; D005500:Follow-Up Studies; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D009181:Mycoses / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D013517:Otorhinolaryngologic Surgical Procedures; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D012852:Sinusitis / Q000276:immunology / Q000382:microbiology* / Q000628:therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D007073:Immunoglobulin E; D011241:Prednisone